{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:12:45Z","timestamp":1784113965823,"version":"3.55.0"},"publisher-location":"Cham","reference-count":167,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031871665","type":"print"},{"value":"9783031871672","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/82_2024_279","type":"book-chapter","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:14:54Z","timestamp":1724930094000},"page":"15-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Brief History of Polyclonal Antibody Therapies Against Bacterial and Viral Diseases Before COVID-19"],"prefix":"10.1007","author":[{"given":"Nigel","family":"Paneth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna","family":"Kornatowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"279_CR1","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/S0140-6736(01)77450-8","volume":"1","author":"AR Aldridge","year":"1898","unstructured":"Aldridge AR (1898) Note on the serum reaction of Mediterranean fever and its treatment by antitoxic plasma. Lancet 1:1394\u20131395","journal-title":"Lancet"},{"key":"279_CR2","unstructured":"Alexander HE (1940) Influenza bacillus infections. In: Jr Holt LE, McIntosh R (eds) Diseases of infancy and childhood, 11th edn. Appleton-Century, New York"},{"key":"279_CR3","first-page":"172","volume":"66","author":"HE Alexander","year":"1943","unstructured":"Alexander HE (1943a) Treatment of Haemophilus influenzae infections and of meningococcic and pneumococcic meningitis. Am J Dis Child 66:172\u2013187","journal-title":"Am J Dis Child"},{"key":"279_CR4","first-page":"160","volume":"66","author":"HE Alexander","year":"1943","unstructured":"Alexander HE (1943b) Experimental basis for treatment of Haemophilus infiuenzae infections. Am J Dis Child 66:160\u2013171","journal-title":"Am J Dis Child"},{"key":"279_CR5","doi-asserted-by":"crossref","unstructured":"Alexander HE, Heidelberger M (1940) Chemical studies on bacterial agglutination. V. Agglutinin and precipitin content of antisera to Haemophilus influenza. J Exp Med 71(1): 1\u201311","DOI":"10.1084\/jem.71.1.1"},{"key":"279_CR6","doi-asserted-by":"crossref","unstructured":"Anders JM (1904) Serum treatment of pneumonia. JAMA 1777\u20131781","DOI":"10.1001\/jama.1904.92500240002j"},{"key":"279_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0140-6736(01)38879-7","volume":"189","author":"FW Andrewes","year":"1917","unstructured":"Andrewes FW (1917) On the intrathecal route for the administration of tetanus antitoxin. Lancet 189:682\u2013686","journal-title":"Lancet"},{"key":"279_CR8","doi-asserted-by":"crossref","unstructured":"Anon (1926) Diphtheria mortality in large cities of the United States in 1925. JAMA 86:1005\u20131007","DOI":"10.1001\/jama.1926.26720400002008"},{"issue":"9","key":"279_CR9","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3201\/eid2209.151164","volume":"22","author":"YM Arabi","year":"2016","unstructured":"Arabi YM, Hajeer AH (2016) Luke T er al: Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia. Emerg Infect Dis 22(9):1554\u20131561","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"279_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s40064-015-1490-9","volume":"19","author":"Y Arabi","year":"2015","unstructured":"Arabi Y, Balkhy H, Hajeer AH et al (2015) Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus 19(4):709","journal-title":"Springerplus"},{"key":"279_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1056\/NEJMoa051926","volume":"354","author":"SS Arnon","year":"2006","unstructured":"Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL (2006) Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 354:462\u2013471","journal-title":"N Engl J Med"},{"key":"279_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2225","volume":"31","author":"JK Aviani","year":"2021","unstructured":"Aviani JK, Halim D, Soeroto AY et al (2021) Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: a systematic review and meta-analysis based on recent studies and previous respiratory pandemics. Rev Med Virol 31:e2225","journal-title":"Rev Med Virol"},{"key":"279_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/bmj.2.3591.830-b","volume":"2","author":"H Banks","year":"1929","unstructured":"Banks H (1929) Intravenous antitoxin in an outbreak of scarlet fever in a public school. Brit Med J 2:50","journal-title":"Brit Med J"},{"issue":"1","key":"279_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1001\/jama.1930.02720010008002","volume":"95","author":"LH Barenberg","year":"1930","unstructured":"Barenberg LH, Lewis JM, Messer WH (1930) Measles prophylaxis: comparative results with the use of adult blood, convalescent serum and immune goat serum. JAMA 95(1):4\u20138","journal-title":"JAMA"},{"key":"279_CR15","first-page":"1145","volume":"50","author":"E Behring","year":"1890","unstructured":"Behring E (1890) Untersuchungen \u03cbber das Zustandekommen der Diphtherie-Immunitat bei Thieren (Investigations into the development of diphtheria immunity in animals). Deutsche Medicinishe Wochenschrift. 50:1145\u20131148","journal-title":"Deutsche Medicinishe Wochenschrift."},{"key":"279_CR16","doi-asserted-by":"crossref","unstructured":"Behring E, Kitasato S (1890) \u03cbber das Zustandekommen der Diphtherie-Immunitat und der Tetanus-Immunitat bei Thieren. (On the development of diphtheria immunity and tetanus immunity in animals). Deutsche Medicinische Wochenschrift 49:1113\u20131114","DOI":"10.1055\/s-0029-1207589"},{"key":"279_CR17","doi-asserted-by":"crossref","unstructured":"Behring EA, Boer O, Kossel H (1893) Zur Behandlung diphtheriekranker Menschen mit Diphtherieheilserum (Treatment of diphtheria sufferers with diphtheria healing serum). Deutsche Medicinische Wochenschrift\u00a017:389\u201393","DOI":"10.1055\/s-0028-1143605"},{"key":"279_CR18","unstructured":"Blackfan KD, Peterson MF, Conroy FC (1923) Use of convalescent serum as a prophylaxis in measles and chickenpox. Ohio State Med Jnl 19:97"},{"key":"279_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jama.1976.03260270028022","volume":"235","author":"PA Blake","year":"1976","unstructured":"Blake PA, Feldman RA, Buchanan TB et al (1976) Serologic therapy of tetanus in the United States, 1965\u20131971. JAMA 235:42\u201344","journal-title":"JAMA"},{"key":"279_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1212\/WNL.29.6.815","volume":"29","author":"JB Bodensteiner","year":"1979","unstructured":"Bodensteiner JB, Morris HH, Howell JT et al (1979) Chronic ECHO type 5 virus meningoencephalitis in X-linked hypogammaglobulinemia: treatment with immune plasma. Neurology 29:815\u2013819","journal-title":"Neurology"},{"key":"279_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/bmj.1.2926.118","volume":"2926","author":"D Bruce","year":"1917","unstructured":"Bruce D (1917) Note on the incidence of tetanus among wounded soldiers. Br Med J 2926:118\u2013119","journal-title":"Br Med J"},{"key":"279_CR22","doi-asserted-by":"crossref","unstructured":"Bryder L (2011) The Medical Research Council and clinical trial methodologies before the 1940s: the failure to develop a \u2018scientific\u2019 approach. J Royal Soc Med 104:335\u2013343","DOI":"10.1258\/jrsm.2011.11k021"},{"key":"279_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1084\/jem.26.1.119.1","volume":"26","author":"CB Bull","year":"1917","unstructured":"Bull CB, Pritchett IW (1917) Toxin and antitoxin and protective inoculation against B. Welchii. J Exp Med 26:119\u2013138","journal-title":"J Exp Med"},{"key":"279_CR24","doi-asserted-by":"crossref","unstructured":"Bullowa JGM: The use of antipneumococcic refined serum in lobar pneumonia: data necessary for a comparison between cases treated with serum and cases not so treated, and the importance of a significant control series of cases. JAMA 90:1354\u20131358","DOI":"10.1001\/jama.1928.02690440010004"},{"key":"279_CR25","doi-asserted-by":"crossref","unstructured":"Carpenter CM, Boak RA (1936) The treatment of human brucellosis. A review of current therapeutic methods. Medicine (Baltimore) 15:103\u2013128","DOI":"10.1097\/00005792-193602000-00002"},{"key":"279_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3201\/eid0808.010516","volume":"8","author":"A Casadevall","year":"2002","unstructured":"Casadevall A (2002) Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis 8:833\u2013841","journal-title":"Emerg Infect Dis"},{"key":"279_CR27","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1128\/AAC.38.8.1695","volume":"38","author":"A Casadevall","year":"1994","unstructured":"Casadevall A, Scharff MD (1994) Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob Agents Chemother 38:1695\u20131702","journal-title":"Antimicrob Agents Chemother"},{"key":"279_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/clinids\/21.1.150","volume":"21","author":"A Casadevall","year":"1995","unstructured":"Casadevall A, Scharff MD (1995) Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis 21:150\u2013161","journal-title":"Clin Infect Dis"},{"key":"279_CR29","doi-asserted-by":"crossref","unstructured":"Casadevall A, Dadachova E, Pirofski LA (2004) Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2:695\u2013703","DOI":"10.1038\/nrmicro974"},{"key":"279_CR30","doi-asserted-by":"crossref","unstructured":"Casadevall A, Joyner MJ, Pirofski LA, Senefeld JW, Shoham S, Sullivan D, Paneth N, Focosi D (2023) Convalescent plasma therapy in COVID-19: unravelling the data using the principles of antibody therapy. Exp Rev Respir Med 17(5):381\u2013395","DOI":"10.1080\/17476348.2023.2208349"},{"key":"279_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1001\/jama.1937.02780090001001","volume":"108","author":"RL Cecil","year":"1937","unstructured":"Cecil RL (1937) Use of very early serum treatment in pneumococcus type I pneumonia. JAMA 108:689\u2013692","journal-title":"JAMA"},{"key":"279_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.1930.02720210001001","volume":"95","author":"RL Cecil","year":"1930","unstructured":"Cecil RL, Plummer N (1930) Pneumococcus type I pneumonia\u2014a study of eleven hundred and sixty-one cases, with especial reference to specific therapy. JAMA 95:1547\u20131553","journal-title":"JAMA"},{"key":"279_CR33","unstructured":"Cenci F (1907) Alcune esperienze di sieroimmunizzazione e sieroterapia nel morbillo (Some experiences of seroimmunization and serotherapy for Measles). Rivista di Clinica e Pediatrica 5:1017\u20131025"},{"key":"279_CR34","first-page":"299","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention (2010) Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR 59:299","journal-title":"MMWR"},{"issue":"1","key":"279_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","volume":"24","author":"Y Cheng","year":"2005","unstructured":"Cheng Y, Wong R, Soo YOY et al (2005) Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 24(1):44\u201346","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"279_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3343\/alm.2016.36.4.393","volume":"36","author":"S Chun","year":"2016","unstructured":"Chun S, Chung CR, Ha YE (2016) Possible transfusion-related acute lung injury following convalescent plasma transfusion in a patient with Middle East Respiratory Syndrome. Ann Lab Med 36(4):393\u2013395","journal-title":"Ann Lab Med"},{"key":"279_CR37","unstructured":"Clinical management of diphtheria: guideline, 2 February 2024, World Health Organization, Geneva, 2024 (WHO\/DIPH\/Clinical\/2024.1). Licence: CC BY-NC-SA 3.0 IGO"},{"key":"279_CR38","doi-asserted-by":"crossref","unstructured":"Cole R (1913) Treatment of pneumonia by use of specific serums. JAMA 61:663","DOI":"10.1001\/jama.1913.04350090031011"},{"key":"279_CR39","first-page":"741","volume":"93","author":"R Cole","year":"1929","unstructured":"Cole R (1929) Serum treatment in type 1 lobar pneumonia. LAMA 93:741\u2013747","journal-title":"LAMA"},{"key":"279_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2307\/4582485","volume":"53","author":"SD Collins","year":"1938","unstructured":"Collins SD (1938) History and frequency of clinical scarlet fever cases and of injections for artificial immunization among 9,000 families, based on nation-wide periodic canvasses, 1928\u201331. Public Health Rep 53:409\u2013427","journal-title":"Public Health Rep"},{"key":"279_CR41","unstructured":"Cooper MS (1964) Antitoxins to C. botulinum. In: Lewis KH, Cassel K (eds) Botulism: proceedings of a symposium. USDHEW, Cincinnati"},{"key":"279_CR42","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2307\/4587476","volume":"38","author":"CC Dauer","year":"1950","unstructured":"Dauer CC (1950) Trends in age distribution of diphtheria in the United States. Public Health Rep 38:1209\u20131218","journal-title":"Public Health Rep"},{"key":"279_CR43","unstructured":"DeKruif P (1949) Life among the doctors. Harcourt, Brace, New York"},{"key":"279_CR44","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jama.1924.02650420010005","volume":"82","author":"GF Dick","year":"1924","unstructured":"Dick GF, Dick GH (1924) A scarlet fever antitoxin. JAMA 82:1246\u20131247","journal-title":"JAMA"},{"key":"279_CR45","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1001\/jama.1925.02670220011003","volume":"85","author":"GF Dick","year":"1925","unstructured":"Dick GF, Dick GH (1925) Therapeutic results with concentrated scarlet fever antitoxin. JAMA 85:1693\u20131695","journal-title":"JAMA"},{"key":"279_CR46","first-page":"293","volume":"54","author":"CD Dolman","year":"1963","unstructured":"Dolman CD, Iida H (1963) Type E botulism: its prevention and specific treatment. Can J Pub Health 54:293\u2013308","journal-title":"Can J Pub Health"},{"key":"279_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1001\/archpedi.1928.01920190021003","volume":"35","author":"RC Eley","year":"1928","unstructured":"Eley RC (1928) Scarlet-fever antitoxin\u2014report of four hundred and sixty-five cases. Am J Dis Child 35:14\u201317","journal-title":"Am J Dis Child"},{"key":"279_CR48","unstructured":"Fibiger J (1898) Om Serumbehandling af Difteri (On the serum treatment of diphtheria). Hospitalstidende 6:309\u2013325, 337\u2013350"},{"issue":"26","key":"279_CR49","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1056\/NEJM193006262022605","volume":"202","author":"M Finland","year":"1930","unstructured":"Finland M (1930) The serum treatment of lobar pneumonia. N Engl J Med 202(26):1244\u20131247","journal-title":"N Engl J Med"},{"issue":"7","key":"279_CR50","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.7326\/0003-4819-14-7-1184","volume":"14","author":"M Finland","year":"1941","unstructured":"Finland M, Lowell FC, Strauss E (1941) Treatment of pneumococcic pneumonias with sulfapyridine, sulfathiazole and serum: analysis of the results of specific therapy at the Boston City Hospital from July 1939 through June 1940. Ann Intern Med 14(7):1184\u20131185","journal-title":"Ann Intern Med"},{"issue":"5","key":"279_CR51","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1084\/jem.17.5.553","volume":"17","author":"S Flexner","year":"1913","unstructured":"Flexner S (1913) The results of the serum treatment in 1300 cases of epidemic meningitis. J Exp Med 17(5):553\u2013576","journal-title":"J Exp Med"},{"issue":"1","key":"279_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1084\/jem.10.1.141","volume":"10","author":"S Flexner","year":"1908","unstructured":"Flexner S, Jobling JW (1908) Serum treatment of epidemic cerebro-spinal meningitis. J Exp Med 10(1):141\u2013203","journal-title":"J Exp Med"},{"key":"279_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jama.1928.02700060017006","volume":"91","author":"S Flexner","year":"1928","unstructured":"Flexner S, Stewart FW (1928) Protective action of convalescent poliomyelitis serum. JAMA 91:383\u2013384","journal-title":"JAMA"},{"key":"279_CR54","doi-asserted-by":"crossref","unstructured":"Flexner S, Amoss HL (1915) The rapid production of antidysenteric serum. J Exp Med 19:515\u2013524","DOI":"10.1084\/jem.21.5.515"},{"key":"279_CR55","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/jama.1932.27320330001009","volume":"98","author":"L Foshay","year":"1932","unstructured":"Foshay L (1932) Serum treatment of tularemia. JAMA 98:552","journal-title":"JAMA"},{"key":"279_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-194002000-00001","volume":"19","author":"L Foshay","year":"1949","unstructured":"Foshay L (1949) Tularemia: a summary of certain aspects of the disease including methods for early diagnosis and the results of serum treatment in 600 patients. Medicine 19:1\u201384","journal-title":"Medicine"},{"key":"279_CR57","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1056\/NEJM193704082161401","volume":"216","author":"LD Fothergill","year":"1937","unstructured":"Fothergill LD (1937) Hemophilus influenzae (Pfeiffer bacillus) meningitis and its specific treatment. New Engl J Med 216:587\u2013590","journal-title":"New Engl J Med"},{"issue":"3","key":"279_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0035-9203(84)90107-X","volume":"78","author":"JD Frame","year":"1984","unstructured":"Frame JD, Verbrugge GP, Gill RG, Pinneo L (1984) The use of Lassa fever convalescent plasma in Nigeria. Trans R Soc Trop Med Hyg 78(3):319\u2013324","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"279_CR59","unstructured":"Francis T Jr, Napier JA, Voight RB et al (1957) Evaluation of the 1954 field trial of poliomyelitis vaccine. Edwards Brothers, Ann Arbor"},{"key":"279_CR60","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0022-3476(42)80006-2","volume":"20","author":"WP Frank","year":"1942","unstructured":"Frank WP, Patton EF, Hamilton PM (1942) Treatment of whooping cough bronchopneumonia. J Pediatr 20:720\u2013722","journal-title":"J Pediatr"},{"key":"279_CR61","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2105\/AJPH.25.5.595","volume":"25","author":"JR Gallagher","year":"1935","unstructured":"Gallagher JR (1935) Use of convalescent measles serum to control measles in a preparatory school. Am J Public Health 25:595\u2013598","journal-title":"Am J Public Health"},{"key":"279_CR62","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1128\/CMR.11.3.514","volume":"11","author":"A Glatman-Freedman","year":"1998","unstructured":"Glatman-Freedman A, Casadevall A (1998) Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev 11:514\u2013532","journal-title":"Clin Microbiol Rev"},{"key":"279_CR63","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/clinids\/21.6.1477","volume":"21","author":"MA Gordon","year":"1995","unstructured":"Gordon MA, Casadevall A (1995) Serum therapy for cryptococcal meningitis. Clin Infect Dis 21:477\u2013479","journal-title":"Clin Infect Dis"},{"key":"279_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(01)23047-5","volume":"1","author":"D Graham","year":"1918","unstructured":"Graham D (1918) Some points in the diagnosis and treatment of dysentery occurring in the British Salonika force. Lancet 1:51\u201355","journal-title":"Lancet"},{"key":"279_CR65","first-page":"170","volume":"2","author":"GA Graham-Smith","year":"1902","unstructured":"Graham-Smith GA (1902) The measures taken to check the diphtheria outbreak of 1901 at Colchester. Epidemiol Infect 2:170\u2013193","journal-title":"Epidemiol Infect"},{"key":"279_CR66","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1542\/peds.6.5.696","volume":"6","author":"WM Hammon","year":"1950","unstructured":"Hammon WM (1950) Possibilities of specific prevention and treatment of poliomyelitis. Pediatrics 6:696\u2013705","journal-title":"Pediatrics"},{"key":"279_CR67","doi-asserted-by":"crossref","unstructured":"Hammon WM, Coriell LL, Stokes J Jr (1952a) Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. I. Plan of controlled field tests and results of 1951 pilot study in Utah. J Am Med Assoc 150(8):739\u2013749","DOI":"10.1001\/jama.1952.03680080001001"},{"key":"279_CR68","doi-asserted-by":"crossref","unstructured":"Hammon WM, Coriell LL, Wehrle PF, Klimt CR, Stokes J Jr (1952b) Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 3. Preliminary report of results based on clinical diagnosis. J Am Med Assoc 150(8):757\u2013760","DOI":"10.1001\/jama.1952.03680080019003"},{"key":"279_CR69","doi-asserted-by":"crossref","unstructured":"Hammon WM, Coriell LL, Stokes J Jr (1952c) Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 2. Conduct and early follow-up of 1952 Texas and Iowa-Nebraska studies. J Am Med Assoc 150(8):750\u2013756","DOI":"10.1001\/jama.1952.03680080012002"},{"key":"279_CR70","unstructured":"Hammon WM, Coriell LL, Wehrle PF, Stokes J Jr (1953) Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses. J Am Med Assoc 151(15):1272\u20131285"},{"key":"279_CR71","doi-asserted-by":"crossref","unstructured":"Hammon WM, Coriell LL, Ludwig ED, McAllister RM, Greene AE, Sather GE, Wehrle PF (1954) Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory-confirmed cases. J Am Med Assoc 156(1):21\u201327","DOI":"10.1001\/jama.1954.02950010023009"},{"key":"279_CR72","first-page":"99","volume":"10","author":"AE Hess","year":"1915","unstructured":"Hess AE (1915) A protective therapy for mumps. Am J Dis Child 10:99\u2013103","journal-title":"Am J Dis Child"},{"issue":"3","key":"279_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7883\/yoken.JJID.2019.382","volume":"73","author":"T Hifumi","year":"2020","unstructured":"Hifumi T (2020) Spontaneous non-traumatic Clostridium perfringens Sepsis. Jpn J Infect Dis 73(3):177\u2013180","journal-title":"Jpn J Infect Dis"},{"key":"279_CR74","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.toxicon.2017.12.043","volume":"141","author":"T Hifumi","year":"2018","unstructured":"Hifumi T, Nakano D, Chiba J et al (2018) Combined therapy with gas gangrene antitoxin and recombinant human soluble thrombomodulin for Clostridium perfringens sepsis in a rat model. Toxicon 141:112\u2013117","journal-title":"Toxicon"},{"key":"279_CR75","doi-asserted-by":"crossref","unstructured":"Hifumi T, Koido Y, Takahashi M (2013) Antitoxin treatment for liver abscess caused by\u00a0Clostridium perfringens. Clin Mol Hepatol 19:97\u201398","DOI":"10.3350\/cmh.2013.19.1.97"},{"key":"279_CR76","unstructured":"Hodes H (1939) Diphtheria. In: Holt LE Jr, McIntosh R (eds) Holt\u2019s diseases of infancy and childhood, 11th edn. Appleton-Century, New York"},{"key":"279_CR77","first-page":"189","volume-title":"Bacteriological and clinical studies of the diarrheal diseases of infancy with reference to the Bacillus dysinteriae (Shiga)","author":"LE Holt","year":"1904","unstructured":"Holt LE (1904) Clinical conclusions. In: Flexner S, Holt LE (eds) Bacteriological and clinical studies of the diarrheal diseases of infancy with reference to the Bacillus dysinteriae (Shiga). Rockefeller Institute, New York, p 189"},{"issue":"18","key":"279_CR78","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.1937.02780180007003","volume":"108","author":"FL Horsfall","year":"1937","unstructured":"Horsfall FL, Goodner K, MacLeod CM et al (1937) Serum as a therapeutic agent in lobar pneumonia. JAMA 108(18):1483\u20131490","journal-title":"JAMA"},{"key":"279_CR79","unstructured":"https:\/\/www.cdc.gov\/botulism\/hcp\/clinical-overview\/index.html#:~:text=Botulism%20Antitoxin%20Heptavalent%20and%20BabyBIG,of%20paralysis%20and%20consequent%20complications"},{"key":"279_CR80","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1378\/chest.12-2907","volume":"144","author":"IFN Hung","year":"2013","unstructured":"Hung IFN, To KKW, Lee C-K et al (2013) Hyperimmune iv immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza a (H1N1) infection. Chest 144:464\u2013473","journal-title":"Chest"},{"key":"279_CR81","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.1933.02740440004002","volume":"101","author":"LW Hunt","year":"1933","unstructured":"Hunt LW (1933) The treatment of scarlet fever with antitoxin. JAMA 101:1444\u20131447","journal-title":"JAMA"},{"key":"279_CR82","first-page":"311","volume":"16","author":"H Iida","year":"1963","unstructured":"Iida H (1963) Specific antitoxin therapy in type E botulism. Japan J Med Sci Biol. 16:311\u2013313","journal-title":"Japan J Med Sci Biol."},{"key":"279_CR83","doi-asserted-by":"crossref","unstructured":"Jochmann G (1906) Versuche zur Serodiagnostik und Serotherapie der epidemischen Genickstarre (Experiments on the serodiagnosis and serotherapy of epidemic nuchal rigidity). Deutsche Medicinische Wochenschrift 1:788\u2013793","DOI":"10.1055\/s-0028-1142033"},{"key":"279_CR84","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2017.37","volume":"17","author":"SHE Kaufmann","year":"2017","unstructured":"Kaufmann SHE (2017) Emil von Behring: translational medicine at the dawn of immunology. Nat Rev Immunol 17:341\u2013343","journal-title":"Nat Rev Immunol"},{"key":"279_CR85","first-page":"1","volume":"27","author":"AN Kingsbury","year":"1927","unstructured":"Kingsbury AN (1927) Watson: the serum prophylaxis of measles. Epidemiol Infect 27:1\u201323","journal-title":"Epidemiol Infect"},{"key":"279_CR86","first-page":"225","volume":"7","author":"S Kitasato","year":"1889","unstructured":"Kitasato S (1889) Uber dem Tetanusbacillus (On the tetanus bacillus). Zeitschr Hyg Infekt 7:225\u2013234","journal-title":"Zeitschr Hyg Infekt"},{"key":"279_CR87","first-page":"833","volume":"28","author":"G Klemperer","year":"1891","unstructured":"Klemperer G, Klemperer F (1891) Versuche uber immunisirung und heilung bei der pneumokokkeninfection (Experiments on immunization and therapy for pneumococcal infection). Berl Klin Wchnschr. 28:833\u2013835","journal-title":"Berl Klin Wchnschr."},{"key":"279_CR88","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/jama.1896.02430810018001f","volume":"27","author":"SS Kneass","year":"1896","unstructured":"Kneass SS (1896) The antitoxin of tetanus. JAMA 27:134\u2013138","journal-title":"JAMA"},{"issue":"7","key":"279_CR89","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3851\/IMP3243","volume":"23","author":"J-H Ko","year":"2018","unstructured":"Ko J-H, Seok H, Cho SY (2018) Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience. Antivir Ther 23(7):617\u2013622","journal-title":"Antivir Ther"},{"key":"279_CR90","first-page":"1","volume":"2","author":"R Koch","year":"1884","unstructured":"Koch R (1884) Die aetiologie der tuberculose (The etiology of tuberculosis). Mittheilungen Aus Dem Kaiserlichen Gesundheitsamt 2:1\u201388","journal-title":"Mittheilungen Aus Dem Kaiserlichen Gesundheitsamt"},{"key":"279_CR91","unstructured":"Koch R (1890) Ueber bakteriologische Forschung (On bacteriological research). Verhandlungen des X Internationalen Medichinischen Congresses, Berlin, 1, 35, August Hirschwald, Berlin"},{"key":"279_CR92","first-page":"489","volume":"12","author":"LK Kong","year":"2006","unstructured":"Kong LK (2006) Successful treatment of avian influenza with Convalescent plasma. Hong Kong Med J 12:489","journal-title":"Hong Kong Med J"},{"key":"279_CR93","doi-asserted-by":"crossref","unstructured":"Kruse W (1903) Die Blutserum therapie bei der Dysenterie (Serum therapy for dysentery). Deutsche Medicinische Wochenschrift, 1:6\u20138","DOI":"10.1055\/s-0028-1138210"},{"key":"279_CR94","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-3476(45)80082-3","volume":"26","author":"JH Lapin","year":"1945","unstructured":"Lapin JH (1945) Serum in the prophylaxis of contacts and the treatment of whooping cough. J Pediatr 26:555\u2013559","journal-title":"J Pediatr"},{"key":"279_CR95","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-3083.1984.tb00931.x","volume":"19","author":"J Lindenmann","year":"1984","unstructured":"Lindenmann J (1984) Origins of the terms \u201cantibody\u201d and \u201cantigen.\u201d Scand J Immunol 19:281\u2013285","journal-title":"Scand J Immunol"},{"key":"279_CR96","doi-asserted-by":"crossref","unstructured":"Linton DS (2000) The obscure object of knowledge: German military medicine confronts gas gangrene during world war I. Bull Hist Med 74:291\u2013316","DOI":"10.1353\/bhm.2000.0081"},{"key":"279_CR97","first-page":"451","volume":"2","author":"F Loeffler","year":"1884","unstructured":"Loeffler F (1884) Untersuchungen \u00fcber die Bedeutung der Mikroorganismen f\u00fcr die Entstehung der Diphtheric beim Menschen, bei der Taube und der Kalbe (Studies on the significance of bacteria in causing diphtheria in man, pigeons and calves). Mitteilung Klinische Gesundheit, Berlin 2:451\u2013499","journal-title":"Mitteilung Klinische Gesundheit, Berlin"},{"key":"279_CR98","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1001\/jama.1941.02820140018005","volume":"116","author":"PF Lucchesi","year":"1941","unstructured":"Lucchesi PF, Gildersleeve N (1941) The treatment of anthrax. JAMA 116:1506\u20131508","journal-title":"JAMA"},{"key":"279_CR99","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/infdis\/58.3.306","volume":"58","author":"EL Lucia","year":"1939","unstructured":"Lucia EL, Welke HF (1939) Trends in the prevalence of diphtheria. J Infect Dis 58:306\u2013317","journal-title":"J Infect Dis"},{"key":"279_CR100","doi-asserted-by":"publisher","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","volume":"145","author":"TC Luke","year":"2006","unstructured":"Luke TC, Kilbane EM, Jackson JL, Hoffman SL (2006) Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med 145:599\u2013609","journal-title":"Ann Intern Med"},{"issue":"2806","key":"279_CR101","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/bmj.2.2806.609","volume":"2","author":"A MacConkey","year":"1914","unstructured":"MacConkey A (1914) Tetanus: its prevention and treatment by means of antitetanic serum. BMJ 2(2806):609\u2013614","journal-title":"BMJ"},{"issue":"4324","key":"279_CR102","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bmj.2.4324.636","volume":"2","author":"MG Macfarlane","year":"1943","unstructured":"Macfarlane MG (1943) Therapeutic value of gas-gangrene antitoxin. Br Med J 2(4324):636\u2013640","journal-title":"Br Med J"},{"key":"279_CR103","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/infdis\/jiu396","volume":"211","author":"J Mair-Jenkins","year":"2015","unstructured":"Mair-Jenkins J, Saavedra-Campos M, Baillie K et al (2015) The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211:80\u201390","journal-title":"J Infect Dis"},{"issue":"8154","key":"279_CR104","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0140-6736(79)92335-3","volume":"2","author":"JI Maiztegui","year":"1979","unstructured":"Maiztegui JI, Fernandez NJ, de Damilano AJ (1979) Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2(8154):1216\u20131217","journal-title":"Lancet"},{"key":"279_CR105","unstructured":"Mamorek A (1895) Le streptocoque et le serum antistreptococique (The streptococcus and antistreptococcal serum). Ann de l\u2019Inst Pasteur 9:592\u2013620"},{"key":"279_CR106","doi-asserted-by":"publisher","unstructured":"Maor Y, Zimhony O (2024) Hyperimmune globulins in COVID-19. Curr Top Microbiol Immunol. https:\/\/doi.org\/10.1007\/82_2024_277","DOI":"10.1007\/82_2024_277"},{"issue":"2","key":"279_CR107","first-page":"152","volume":"14","author":"G Marano","year":"2016","unstructured":"Marano G, Vaglio S, Pupella S et al (2016) Convalescent Plasma: new evidence for an old therapeutic tool. Blood Transfus 14(2):152\u2013157","journal-title":"Blood Transfus"},{"key":"279_CR108","unstructured":"Marchoux E (1895) Serum anticharbonneux (Antianthrax serum). Annales de l\u2019institut Pasteur 9:785"},{"key":"279_CR109","unstructured":"Martinez Pintos IF et al (1961) Nuestra experiencia en el tratamiento del \u201cmal de los rastrojos\u201d (Our experience with the treatment of \u201cstubble disease\u201d). Sem Med (B Aires) 118:856\u2013864"},{"key":"279_CR110","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/00007890-199605150-00013","volume":"61","author":"RW McGory","year":"1996","unstructured":"McGory RW, Ishitani MB, Oliveira WM et al (1996) Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 61:1358\u20131364","journal-title":"Transplantation"},{"key":"279_CR111","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0022-3476(40)80037-1","volume":"16","author":"AC McGuinness","year":"1940","unstructured":"McGuinness AC, Bradford WL, Armstrong JC (1940) The production and use of hyperimmune human whooping cough serum. J Pediatr 16:21\u201329","journal-title":"J Pediatr"},{"key":"279_CR112","doi-asserted-by":"crossref","unstructured":"Medical Research Council (1934) The serum treatment of lobar pneumonia. A report of the therapeutic trials committee of the Medical Research Council. Lancet 1:290\u2013295","DOI":"10.1016\/S0140-6736(00)43968-1"},{"key":"279_CR113","first-page":"1053","volume":"15","author":"P Moser","year":"1902","unstructured":"Moser P (1902) Ober die Behandlung des Scharlachs mit einer Schar\u00ad lachstreptokkenserum (On the treatment of scarlet fever with an anti-streptoccal serum) Wien. Klin Wchnschr 15:1053\u20131055","journal-title":"Klin Wchnschr"},{"key":"279_CR114","doi-asserted-by":"crossref","unstructured":"Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M et al (1999) Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International scientific and technical committee. J Infect Dis 179(Suppl 1):S18\u2013S23","DOI":"10.1086\/514298"},{"key":"279_CR115","first-page":"31348221129515","volume":"23","author":"DK Nakayama","year":"2022","unstructured":"Nakayama DK (2022) The Christmas miracle of Emil von Behring. Am Surg 23:31348221129515","journal-title":"Am Surg"},{"key":"279_CR116","first-page":"305","volume":"98","author":"NS Nation","year":"1963","unstructured":"Nation NS, Pierce NF, Adler SJ, Chinnock RF, Wehrle PF (1963) Tetanus: the use of human hyperimmune globulin in treatment. Calif Med 98:305\u2013307","journal-title":"Calif Med"},{"key":"279_CR117","unstructured":"Netter A, Gendron A, Touraine (1911) Serotherapie de la poliomyelite anterieure aigue (serotherapy of acute anterior poliomyelitis). Comptes Rendu Des S\u00e9ance De Societe De Biologie 70:625"},{"key":"279_CR118","unstructured":"Nicolle C, Conseil E (1918) Pouvoir preventif du serum d\u2019un malade convalescent de rougeole (Preventive power of serum from a patient convalescing from measles). Bulletins et M\u00e9moires de la Soci\u00e9t\u00e9 M\u00e9dicale des H\u00f4pitaux de Paris 42:336"},{"key":"279_CR119","unstructured":"Nocard, E (1897) Sur la s\u00e9roth\u00e9rapie du t\u00e9tanos (On the serotherapy of tetanus). Receuil M\u00e9d. V\u00e9t. 8e s\u00e9rie, tome 4:481\u2013490"},{"key":"279_CR120","doi-asserted-by":"crossref","unstructured":"O\u2019Horo JC Harper EP, El Rafei A (2017) Efficacy of antitoxin therapy in treating patients with foodborne botulism: a systematic review and meta-analysis of cases, 1923\u20132016. Clin Infect Dis 66(suppl_1):S43\u2013S66","DOI":"10.1093\/cid\/cix815"},{"issue":"376","key":"279_CR121","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o295","volume":"8","author":"N Paneth","year":"2022","unstructured":"Paneth N, Casadevall A, Pirofski L-A et al (2022) WHO covid-19 drugs guideline: reconsider using convalescent plasma. BMJ 8(376):o295","journal-title":"BMJ"},{"key":"279_CR122","first-page":"1439","volume":"42","author":"WH Park","year":"1931","unstructured":"Park WH (1931) The history of diphtheria in New York City. Am J Dis Child 42:1439\u20131445","journal-title":"Am J Dis Child"},{"key":"279_CR123","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jama.1932.02740650008003","volume":"99","author":"WH Park","year":"1932","unstructured":"Park WH (1932) Therapeutic use of antipoliomyelitis serum in preparalytic cases of poliomyelitis. JAMA 99:1050\u20131053","journal-title":"JAMA"},{"key":"279_CR124","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/jama.1926.02680080022009","volume":"87","author":"WH Park","year":"1926","unstructured":"Park WH, Freeman RG (1926) The prophylactic use of measles convalescent serum. JAMA 87:556\u2013558","journal-title":"JAMA"},{"key":"279_CR125","volume-title":"A history of poliomyelitis","author":"JR Paul","year":"1971","unstructured":"Paul JR (1971) A history of poliomyelitis. Yale University Press, New Haven"},{"key":"279_CR126","doi-asserted-by":"crossref","unstructured":"Pfeiffer R (1893) Die Atiologie der Influenza (The etiology of influenza). Zeitschrift f\u00fcr Hygiene und Infektionskrankheiten 18:357","DOI":"10.1007\/BF02284284"},{"key":"279_CR127","unstructured":"Platzer RF (1945) Evaluation of therapeutic agents in plague. A review of the literature. US Naval Med Bull 46:1674\u20131688"},{"issue":"1","key":"279_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archpedi.1946.02020240008001","volume":"71","author":"AC Rambar","year":"1946","unstructured":"Rambar AC (1946) Mumps: use of convalescent serum in the treatment and prophylaxis of orchitis. Am J Dis Child 71(1):1\u201313","journal-title":"Am J Dis Child"},{"key":"279_CR129","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1056\/NEJM191912111812406","volume":"161","author":"WR Redden","year":"1919","unstructured":"Redden WR (1919) Treatment of influenza-pneumonia by use of convalescent human serum. Boston Med Surg J 161:688\u2013691","journal-title":"Boston Med Surg J"},{"key":"279_CR130","doi-asserted-by":"crossref","unstructured":"Regan J (1919) The local use of antianthrax serum in the treatment of anthrax. JAMA 72:1724\u20131725","DOI":"10.1001\/jama.1919.02610240012003"},{"key":"279_CR131","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jama.1921.02630390064044","volume":"77","author":"JC Regan","year":"1921","unstructured":"Regan JC (1921) The local and general treatment of cutaneous anthrax. JAMA 77:1044\u20131048","journal-title":"JAMA"},{"key":"279_CR132","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2105\/AJPH.2004.040790","volume":"95","author":"CR Rinaldo","year":"2005","unstructured":"Rinaldo CR (2005) Passive immunization against poliomyelitis. Am J Pub Health 95:790\u2013799","journal-title":"Am J Pub Health"},{"key":"279_CR133","first-page":"383","volume-title":"Preventive Medicine and Hygiene","author":"MJ Rosenau","year":"1913","unstructured":"Rosenau MJ (1913) Preventive Medicine and Hygiene. Appleton, New York, p 383"},{"key":"279_CR134","first-page":"640","volume":"8","author":"E Roux","year":"1894","unstructured":"Roux E, Martin L, Chaillou A (1894) Trois cent cas de diphtherie traite par le serum antidiphtherique (Three hundred cases of diphtheria treated using anti-diphtheria serum). Annales De L\u2019institut Pasteur 8:640\u2013661","journal-title":"Annales De L\u2019institut Pasteur"},{"key":"279_CR135","unstructured":"Roux E, Yersin A (1888) Contribution \u00e0 l\u2019\u00e9tude de la dipht\u00e9rie\u00a0(Contributions to the study of diphtheria). Annales de l\u2019 Institut Pasteur 2:629\u2013661"},{"key":"279_CR136","unstructured":"Rowland S (1912) Serum treatment of human plague in: Seventh report on plague investigations in India. J Hyg 12 (Plague Supplement lvi):326\u2013339"},{"key":"279_CR137","unstructured":"Ruggiero HA, P\u00e9rez Isquierdo F, Milani HA, Barri A, Val A, Maglio F et al (1986) Treatment of Argentine hemorrhagic fever with convalescent\u2019s plasma. 4433 cases. Presse Med 15(45):2239\u20132242"},{"key":"279_CR138","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0022-3476(44)80191-3","volume":"25","author":"IE Scheinblum","year":"1944","unstructured":"Scheinblum IE, Bullowa JGM (1944) The treatment of pertussis with lyophile hyperimmune human pertussis serum. J Pediatr 25:49\u201355","journal-title":"J Pediatr"},{"key":"279_CR139","unstructured":"Sclavo S (1903) Sullo stato presente della serioterapia anticarbonchiosa (On the present state of antianthrax serotherapy). Rivista d\u2019Igiene e di Santa Publica 14:519"},{"key":"279_CR140","volume-title":"Experimental and quasi-experimental designs for generalized causal inference","author":"WR Shadish","year":"2002","unstructured":"Shadish WR, Cook TD, Campbell DT (2002) Experimental and quasi-experimental designs for generalized causal inference. Houghton-Mifflin, Boston"},{"key":"279_CR141","first-page":"599","volume":"23","author":"K Shiga","year":"1898","unstructured":"Shiga K (1898) Ueber den Erregerder Dysenterie in Japan (On the causative agents of dysentery in Japan). Vorlaufige Mitteilung. Zentralbl Bakteriol Microbiol Hyg 23:599\u2013600","journal-title":"Vorlaufige Mitteilung. Zentralbl Bakteriol Microbiol Hyg"},{"key":"279_CR142","first-page":"120","volume":"15","author":"K Shiga","year":"1936","unstructured":"Shiga K (1936) The trend of prevention, therapy and epidemiology of dysentery since the discovery of its causative organism. NEJM 15:120\u2013211","journal-title":"NEJM"},{"key":"279_CR143","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0022-3476(37)80078-5","volume":"10","author":"N Silverthorne","year":"1937","unstructured":"Silverthorne N, Fraser DT, Snelling CE (1937) Influenzal meningitis. J Pediatr 10:228\u2013323","journal-title":"J Pediatr"},{"key":"279_CR144","unstructured":"Sokhey SS (1936) Un nouveau serum antipesteux (A new antiplague serum). Bull Office Internat. d\u2019hygiene Publique e 28:1097\u20131100"},{"key":"279_CR145","doi-asserted-by":"crossref","unstructured":"Spaeth R (1941) Therapy of tetanus. A study of two hundred and seventy-six cases. Arch Intern Med 68:1133\u20131160","DOI":"10.1001\/archinte.1941.00200120092008"},{"key":"279_CR146","doi-asserted-by":"crossref","unstructured":"Stokes J Jr, Wolman IJ, Carpenter HC et al (1935) Prophylactic use of parents\u2019 whole blood in anterior poliomyelitis: Philadelphia epidemic of 1932. Am J Dis Child 50(3):581\u2013595","DOI":"10.1001\/archpedi.1935.01970090011002"},{"key":"279_CR147","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jama.1931.02720440013004","volume":"96","author":"WD Sutliff","year":"1931","unstructured":"Sutliff WD, Finland M (1931) Type 1 lobar pneumonia treated with concentrated pneumococcic antibody (Felton)\u2014the clinical course. JAMA 96:1465\u20131469","journal-title":"JAMA"},{"key":"279_CR148","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1056\/NEJM193402012100501","volume":"210","author":"WD Sutliff","year":"1934","unstructured":"Sutliff WD, Finland M (1934) Type 1 pneumococcic infection with especial reference to specific serum treatment. NEJM 210:237\u2013245","journal-title":"NEJM"},{"key":"279_CR149","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","volume":"76","author":"CO Tacket","year":"1984","unstructured":"Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA (1984) Equine antitoxin use and other factors that predict outcome in type A food\u00adborne botulism. Am J Med 76:794\u2013798","journal-title":"Am J Med"},{"issue":"2240","key":"279_CR150","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1136\/bmj.2.2240.1456","volume":"2","author":"C Todd","year":"1903","unstructured":"Todd C (1903) On a dysentery antitoxin. Br Med J 2(2240):1456\u20131458","journal-title":"Br Med J"},{"key":"279_CR151","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00000441-191609000-00009","volume":"152","author":"RG Torrey","year":"1916","unstructured":"Torrey RG (1916) Influenzal meningitis with report of a case. Am J Med Sci 152:403","journal-title":"Am J Med Sci"},{"key":"279_CR152","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/jama.1919.02610300003002","volume":"73","author":"FT Van Beuren","year":"1919","unstructured":"Van Beuren FT (1919) The treatment of gas bacillus infection. JAMA 73:239\u2013242","journal-title":"JAMA"},{"key":"279_CR153","first-page":"1","volume":"26","author":"E Van Ermengem","year":"1897","unstructured":"Van Ermengem E (1897) Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus (On a new anaerobic bacillus and its relationship to botulism). Zeitschrift fur Hygiene und Infektionskrankheiten 26:1\u201356","journal-title":"Zeitschrift fur Hygiene und Infektionskrankheiten"},{"key":"279_CR154","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.2307\/4580280","volume":"51","author":"MV Veldee","year":"1931","unstructured":"Veldee MV, Stevenson FE, Mitchell EG (1931) Scarlet fever streptococcus antitoxin in the treatment of scarlet fever. Public Health Rep 51:3023\u20133050","journal-title":"Public Health Rep"},{"key":"279_CR155","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2105\/AJPH.19.12.1287","volume":"19","author":"AB Wadsworth","year":"1929","unstructured":"Wadsworth AB (1929) The hemolytic streptococci and anti streptococcus serum in scarlet fever. Am J Public Health 19:1287\u20131302","journal-title":"Am J Public Health"},{"key":"279_CR156","first-page":"29","volume":"76","author":"PM Wagle","year":"1941","unstructured":"Wagle PM, Sokhey SS, Dikshit BB et al (1941) Chemotherapy in Plague. Ind Med Gaz 76:29\u201332","journal-title":"Ind Med Gaz"},{"key":"279_CR157","doi-asserted-by":"crossref","unstructured":"Washbourn JM (1897) Anti-pneumoccic serum. BMJ 1:510\u2013514","DOI":"10.1136\/bmj.1.1887.510"},{"key":"279_CR158","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.1924.02650420009004","volume":"82","author":"AA Weech","year":"1924","unstructured":"Weech AA (1924) The prophylaxis of varicella with convalescent\u2019s serum. JAMA 82:1245\u20131246","journal-title":"JAMA"},{"key":"279_CR159","unstructured":"Weinberg M, Seguin P (1918) La Gangrene Gazeuse (Gas Gangrene). Masson et Cie, Paris"},{"key":"279_CR160","unstructured":"Welch WH, Nuttall GHE (1892) A gas producing bacillus (Bacillus aerogenes capsulatus, nov. spec.) capable of rapid development in the blood vessels after death. Bull Johns Hopkins Hosp 3:81"},{"key":"279_CR161","doi-asserted-by":"crossref","unstructured":"Wesselhoeft C (1942) Mumps. New Engl J Med 226:530\u2013534","DOI":"10.1056\/NEJM194203262261305"},{"issue":"3","key":"279_CR162","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/ijms22031308","volume":"22","author":"NA Wong","year":"2021","unstructured":"Wong NA, Saier MH (2021) The SARS-coronavirus infection cycle: a survey of viral membrane proteins, their functional interactions and pathogenesis. Int J Mol Sci 22(3):1308","journal-title":"Int J Mol Sci"},{"issue":"9","key":"279_CR163","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jama.1939.02800340015005","volume":"113","author":"WB Wood","year":"1939","unstructured":"Wood WB (1939) Treatment of pneumococcic pneumonia with concentrated antipneumococcus rabbit serum. JAMA 113(9):745\u2013749","journal-title":"JAMA"},{"key":"279_CR164","unstructured":"World Health Organization (2014) Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks: interim guidance for national health authorities and blood transfusion services. World Health Organization"},{"key":"279_CR165","volume-title":"The autumn ghost: how the battle against a polio epidemic revolutionized modern medical care","author":"H Wunsch","year":"2023","unstructured":"Wunsch H (2023) The autumn ghost: how the battle against a polio epidemic revolutionized modern medical care. Greystone Books, Vancouver"},{"key":"279_CR166","unstructured":"Yersin A, Calmette A, Borrel A (1895) La peste bubonique. Deuxieme note. (Bubonic Plague, 2nd note). Ann Inst Pasteur 9:589\u2013592"},{"key":"279_CR167","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMc070359","volume":"357","author":"B Zhou","year":"2007","unstructured":"Zhou B, Zhong N, Guan Y (2007) Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357:1450\u20131451","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1007\/82_2025_295","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000}}],"container-title":["Current Topics in Microbiology and Immunology","Convalescent Plasma and Other Antibody Therapies for Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2024_279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:02:11Z","timestamp":1784113331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2024_279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031871665","9783031871672"],"references-count":167,"URL":"https:\/\/doi.org\/10.1007\/82_2024_279","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"30 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"10 May 2025","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"A correction has been published.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}